tosed by pulmonary macrophages, which become activated and release inflammatory mediators, such as reactive oxygen intermediates, arachidonic acid metabolites, chemokines, and cytokines 2) .
ROS cause direct tissue injury and activation of alveolar macrophages to undergo apoptosis 3, 4) , enhance the synthesis of proinflammatory cytokines 5) , and augment the induction of inflammatory responses. On the other hand, ROS production can be down-regulated by antioxidants, such as vitamin C and E, and heme oxygenase. This enzyme was increased in lungs in silicotic mice and humans; it suppresses ROS activity, and attenuates disease progression 6) .
Exhaled breath condensate (EBC) examination appears to be a simple and non-invasive method for studying lower respiratory tract events in vivo 7) . EBC contains several biomarkers of inflammation and oxidative stress, and collection can be repeated several times without any adverse effects, even in severely ill patients. Oxidative stress can be quantified in a biologic specimen by measuring the products of the effect of oxidative stress. A large body of evidence accumulated over past decade, indicating that quantification of isoprostanes, unique products of lipid peroxidation, provides a reliable marker of oxidant injury both in vitro and in vivo. An increase in the examined fluid of 8-isoprostane, a stable prostaglandin-F2-like compound, originating from a major pathway of arachidonic acid disposition, indicates that there is ongoing lipid peroxidation that is incompletely suppressed by anti-oxidant defenses 8) .
Additionally, 8-isoprostane has been seen to increase in bronchoalveolar lavage in subjects with interstitial lung diseases, such as cryptogenic fibrosing alveolitis 9) , and recently in EBC of such patients 10) . However, no study on patients with silicosis has yet been published.
Leukotrienes are pro-inflammatory and pro-fibrogenic mediators derived from the 5-lipoxygenase pathway of arachidonic acid metabolism.
The two classes of leukotrienes are leukotriene B4 and cysteinyl-leukotrienes (C4, D4, and E4). Leukotriene B4 is recognized as a potent leukocyte chemoattractant and activator; cysteinylleukotrienes, by contrast, are best recognized for their role in the pathogenesis of asthma. It has been reported, however, that patients with idiopathic pulmonary fibrosis exhibit overproduction of both leukotriene B4 and cysteinyl-leukotrienes in the lung 11) . Cysteinyl leukotrienes play an important role in inflammation and remodeling of the airways. It was found recently that human bronchial fibroblasts may also generate both cysteinyl leukotrienes and leukotriene B4 12) . The levels of leukotrienes B4 and C4 in homogenates of lung tissue obtained from patients with newly diagnosed, untreated interstitial pulmonary fibrosis were increased, as compared to control subjects.
Leukotrienes participate in the pathogenesis of pulmonary fibrosis, and they may do so by direct effects on migration, proliferation and matrix protein synthesis by fibroblasts, as well as by indirect effects, such as suppression of lung mononuclear production of antifibrogenic cytokines 13) .
Both 8-isoprostane and leukotriene B4 were described to rise during chronic obstructive pulmonary disease exacerbations 14) . Additionally, the influence of recent smoking, another source of ROS, on the concentrations of 8-isoprostane 15) and leukotriene B4 in breath condensate has been described 16, 17) .
There is also a non resolved question of potentional nephrotoxicity of silica. Results of published studies dealing with the association of the risk of kidney damage or vasculitis and silica exposure are controversial. Association of kidney damage with silica exposure was found in some but not in all studies [18] [19] [20] [21] . In our previous study, significantly higher antineutrophil cytoplasmic antibodies (ANCA) positivity (p=0.002) and borderline tubular resorption impairment (p=0.049) was seen in subjects with silicosis, comparing with the controls 22) .
Materials and Methods
Patients with silicosis (58 men and 2 women) came to the Department of Occupational medicine for regular follow-up due to their past exposure. Before silicosis could be acknowledged as an occupational disease, significant exposure had been confirmed by industrial hygienists. The most common occupations were: miner in metal ore mines, tunneler, foundry worker, stone-cutter or ceramic factory worker. Silica concentration in the air varied from less than 1 mg to 270 mg per cubic meter, greatly exceeding the maximum allowed concentration of 2 mg per cubic meter. The silica content in the dust was in the range of 3-96%. The respirable fraction of the fibrogenic dust also varied widely, as did technical equipment and personal protection use at different workplaces. Silica exposure was classified as medium or high based on the evaluation of the industrial hygienist (concentration, duration, technical and personal equipment). Data on the patients and controls are given in Table 1 . In silicotics, 28.3% of subjects were using diuretics. The percentage in patients with simple and complicated silicosis was 21.6 and 39.1, respectively. Among silicotics, 21.7% of patients were treated with beta blockers. The percentage in patients with simple and complicated silicosis was 16.2 and 30.4, respectively.
According to the findings on the chest radiographs, there were 37 patients with simple silicosis.
This occupational disease was diagnosed, according to the national legislation, in subjects fulfilling the follow-EXHALED BREATH CONDENSATE IN PATIENTS WITH SILICOSIS ing criteria for silicosis: a finding of p2/2, q1/1, r1/1 or higher profusion, according to ILO classification of radiographs 23) . Complicated silicosis was seen in 23 patients (ILO classification A, B, C, i.e. opacities with diameter 10 mm and larger).
Patients with mixed exposures (asbestos, organic solvents, etc.) were excluded from the study.
The control group was composed of 25 subjects (23 men and 2 women), previously working as office employees and safety inspectors, never occupationally exposed to fibrogenic dusts. The subjects underwent the same examination as the silica-exposed patients, with the exception of chest radiographs. Exacerbation of chronic bronchitis and treatment with antibiotics were exclusion criteria in both groups. Control subjects were matched in age, sex, body mass index, smoking and alcohol consumption with the patients with silicosis (Table 1 ). In the control group, 12.0% of the subjects used diuretics and 16.0% beta blockers.
Informed consent was obtained from each participant prior to taking blood samples for the following tests: blood count, erythrocyte sedimentation (ESR), liver enzymes, bilirubin, cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, urea, creatinine, α1-antitrypsin, α1-microglobulin, ANCA and rheumatoid factor, which were measured by standard laboratory methods. Urinalysis for proteinuria and cotinine was also performed. All persons received a routine medical examination and a questionnaire, administered by the study staff personnel. Clinical data were collected to search for factors potentially influencing oxidative stress, such as medical history, medication, as well as for the dyspnoea category 24) .
Lung functions were measured using a bodyplethysmograph (Jaeger, Germany) in all subjects. The study was carried out according to the Helsinki Declaration and approved by the university ethics committee.
The smokers in our study were restricted from smoking at least 2 h before collection of breath condensate. In addition, cotinine in the urine was measured.
EBC samples were collected using the EcoScreen (Jaeger, Germany) according to the manufacturer's instructions. After rinsing their mouths, all recruited subjects breathed tidally through a mouthpiece that was connected through a unique one-way valve into a cooled collection tube where vapors, aerosols and moisture condense along the walls of the tube. Each subject was asked to breathe through the collection kit for 15 min with more than 2 ml of EBC collected. Samples were immediately frozen after collection (-80˚C) and stored for a period not exceeding 1 month. Contamination of saliva in the EBC was determined by the colorimetric detection of α-amylase (α-Amylase-Liquid BIO-LA-TEST kit, PlivaLachema, Czech Republic), and samples where α-amylase was detected were excluded from further analysis.
Analytical methods
8-isoprostane in exhaled breath condensate was analyzed after immunoaffinity separation using LC-ESI-MS (liquid chromatography -electrospray ionization-mass spectrometry), where multiple reaction monitoring (MRM) mode was used for its extremely high degree of selectivity, and stable-isotope-dilution assay for its high precision of quantification. The combination of mass spectrometry detection with separation on a high-performance liquid chromatography (HPLC) column retains the analyte from the solvent front and avoids co-elution of salts and endogenous matrix components which can suppress the ionization of the analyte during the ESI. The analytical procedure was optimized and validated. The limit of detection (LOD) for 8-isoprostane was determined to be 1 pg/ml, and the limit of quantification (LOQ) 5 pg/ml; recovery was 84% and precision was statistically evaluated as 8%. The method was modified for parallel quantification of leukotriene B4 and the group of cysteinyl leukotriens by extension of the pretreatment method for immunoseparation mediated by resin with anchored antibody against leukotrienes and identical LC-ESI-MS detection in MRM mode developed for each particular component. LOD, LOQ and recovery for a particular analyte were as follows: leukotriene B4-LOD=1 pg/ml; LOQ=4 pg/ml; recovery=46%; leukotriene C4-LOD=2 pg/ml; LOQ=16 pg/ml; recovery=55%; leukotriene D4-LOD=1 pg/ml; LOQ=6 pg/ml; recovery=61%; leukotriene E4-LOD=1 pg/ml; LOQ=5 pg/ml; recovery=81%.
Cotinine in the urine was determined by gas chromatography/mass spectrometry (SIM mode) after extraction with ethyl acetate at pH 10 (LOQ 50 ng/ml, linearity fulfilled in the range 50-1,000 ng/ml with the correlation coefficient 0.9994). Urine samples were taken before exhaled breath condensate collection.
Statistical analysis
Student's t-test (for equal variances and for equal means), F-test, ANOVA, χ 2 and linear regression (correlation coefficient) methods were used for statistical comparison of the groups.
Results
Several lung functions parameters were impaired in exposed subjects in comparison with the controls; ESR, α1-antitrypsin and proteinuria were higher in silicotics, as can be seen in Table 2 .
The mean level of 8-isoprostane and leukotriene D4 was higher in the patients with silicosis than in the controls. The differences between patients with simple and complicated silicosis were not significant.
Patients with complicated silicosis more frequently had high levels of 8-isoprostane, where controls had low levels, as can be seen in Table 3 . Comparison of the average 8-isoprostane levels in the silicotics and controls is shown in Table 4 , distribution of 8-isoprostane level in Table 5 .
Results of 8-isoprostane for silica exposure level were similar, as shown in Table 6 .
Cotinine was found in the urine of smokers in both groups; the levels in all silica-exposed patients were in the range of 0-1,143 ng/ml; in the controls 0-430 ng/ml.
When lung function parameters in the silicotics were correlated with 8-isoprostane and all leukotrienes levels, there were several positive correlations with impaired lung function parameters; however other markers in the EBC were negatively correlated with parameters of lung function, indicating impairment.
The 8-isoprostane level was positively associated in all subjects with diuretics (p=0.0058) and beta blockers (p=0.0349) treatment (calculated using χ 2 -test).
The average level of 8-isoprostane was significantly higher in subjects with diuretics treatment, comparing with subjects without diuretics (86 ± 10 pg/ml and 58.2 ± 8.1 pg/ml, respectively; p=0.017). However, average level of 8-isoprostane was not different in subjects treated and non-treated with beta blockers (67 ± 27 pg/ml and 64.1 ± 8.1 pg/ml, respectively, p=0.826).
If only group of people with silicosis was evaluated, 8-isoprostane level was higher in subjects treated with diuretics than in subjects without diuretics treatment (90 ± 23 pg/ml, and 67 ± 11 pg/ml, respectively; p=0.044). On the other hand, in patients with silicosis, 8-isoprostane level did not differ in those using beta blockers, as compared to subjects without beta blockers (80 ± 32 pg/ml, 72 ± 10 pg/ml respectively, p=0.64).
In the control group the difference in 8-isoprostane level was not significant either for diuretics (p=0.479) or for beta blockers treatment (p=0.157).
In the silicotics, 8-isoprostane correlated negatively with α1-antitrypsine concentration (p=0.007).
Leukotriene B4 levels were in all subjects positively associated in all subjects only with ischemic hearth disease (p=0.0323) and treatment with diuretics (p= 0.0337).
In the silicotics, leukotriene B4 correlated negatively with α1-antitrypsine concentration (p= 0.024).
In the controls, leukotriene B4 correlated positively with urea (p=0.017), negatively with bilirubin (p=0.019), and HDL cholesterol (p=0.036).
Leukotriene C4 in all subjects was positively associated with chronic obstructive pulmonary disease (p=0.0405) and negatively with fibrates treatment (p=0.0205). In all subjects it correlated positively with urine cotinine concentration (p=0.046), in silicotics negatively with creatinine level (p=0.015). In the controls it correlated negatively with alkaline phosphatase (p=0.021).
Leukotriene D4 was slightly positively associated with the group of subjects (simple, complicated silicosis or control) (p=0.0596). In the controls it correlated positively only with alanine aminotransferase (p=0.035).
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Leukotriene E4 was also associated with the group of subjects (simple, complicated silicosis or control) (p=0.0022), with the level of silica exposure (high, medi- cholesterol (p=0.020), and with LDL cholesterol (p=0.040).
In the controls, leukotriene E4 correlated negatively with hematocrit (p=0.037) and with hemoglobin (p=0.047).
Only very low probabilities of correlations were recorded among 8-isoprostane or leukotrienes and smoking, daily alcohol consumption, history of allergic diseases, pleuritis, pneumonia, tuberculosis, kidney, liver, gall bladder disease, hypertension, diabetes, and cerebral stroke or cerebral injury.
When the effect of smoking on the markers from the EBC was evaluated, differences in 8-isoprostane and leukotriene D4 (p=0.001, p=0.009, respectively) were confirmed as significant among both exposed and control non-smokers. Differences in 8-isoprostane were borderline significant among exposed and control smokers (p=0.052); the number of smokers among the controls was only 8 subjects.
The influence of daily vitamin intake on the markers studied was also evaluated. Because the group of silicotics who took vitamins daily comprised only three subjects, it could not be compared with controls with daily vitamin intake. When only those who did not take vitamins daily from both groups were compared, the difference between 8-isoprostane (p=0.00046) and leukotriene D4 (p=0.00038) was significant.
ANCA positivity was significantly more frequent in the silicotics. However, a higher or significant association with ANCA positivity and EBC marker level was not found.
Discussion
Several experimental studies 25, 26) have proven the importance of oxidative stress in the pathophysiology of silica-induced diseases. In this study, mean 8-isoprostane and leukotriene D4 in the EBC was increased in silicotics, as compared to the control group. In addition, a dosedependent correlation was seen for the level of silica exposure and 8-isoprostane. 8-isoprostane and leukotriene D4 showed a positive association with the severity of the disease, i.e. complicated silicosis. In addition, leukotriene E4 had a milder association with complicated silicosis, a strong association with chronic cough, and borderline with dyspnoea.
Mean leukotriene B4 level was not higher in silicotics, but its level was positively associated with ischemic hearth disease and treatment with diuretics. On the other hand, leukotriene C4 appeared to correlate in all subjects with cotinine in the urine and with chronic obstructive pulmonary disease.
In the silicotics, the percentage of subjects treated with diuretics and beta blockers was relatively high. The category of 8-isoprostane level was positively associated with diuretics treatment which can indirectly result from complicated silicosis and right hearth failure. The other significantly increased marker in silicotics, leukotriene D4, was not associated with using this medication. Lung functions were not associated with significant changes in 8-isoprostane and leukotrienes in the EBC. Cotinine in the urine was positively associated with leukotriene C4. The effect of recent smoking on most markers in the EBC was not confirmed, which can be explained by the fact that our smokers were restrained from smoking at least 2 hours before EBC collection.
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In the control group, several positive or negative associations with liver tests and other biochemical and hematological parameters were seen; however, their real significance is not clear. Negative correlation of bilirubin, water soluble antioxidant 27) in serum with markers in the EBC was found.
No correlation of 8-isoprostane and leukotrienes with body mass index, glycemia, renal functions, proteinuria, alcohol intake, smoking or cigarette pack-yr was observed. Several diseases, such as ischemic heart disease, hypertension, diabetes, kidney, liver, gall bladder disease, and cerebral stroke or cerebral injury were described to increase serum and urine markers of oxidative stress 28) . Systemic disorders associated with oxidative stress increase serum and urine 8-isoprostane levels; elevation of markers in the EBC, on the other hand, points to respiratory disorders. It is not known to what extent systemic diseases are able to influence the level of markers in EBC. In this study, among non-respiratory disorders, only the association of leukotriene B4 with ischemic hearth disease was observed.
Silica particles are involved in the biotransformation of arachidonic acid by alveolar macrophages, and antioxidants such as vitamin E were beneficial in reducing the proinflammatory response in in vivo experiments in rats 29) . In our study, however, daily vitamin intake did not positively influence the results, as significant differences were also seen between the silicotics and controls who did not take vitamins daily.
Here, α1-antitrypsin was higher in silicotics. These results are in agreement with our study 22) , where silicosis was significantly associated with ANCA positivity, and ANCA-positive patients had significantly higher serum α1-antitrypsin concentration.
Limitations of the study
EBC analysis is not yet considered a standard clinical tool. There are still two problems with the EBC approach which must be overcome before it can become a useful clinical method 30) . The first is related to the dilution of respiratory droplets in exhaled water vapor and the second to the uncertainty regarding the sites of generation of the droplets of "respiratory" fluid that are present in the EBC. However, according to a recently published study by Effros et al. 31) , mean values of dilution were not significantly different between normal and COPD subjects. Therefore, differences between these populations could really be attributed to differences in respiratory fluid concentration rather than the number of droplets found. As respiratory droplets represent less than 0.01% of the EBC, the concentrations of markers in the EBC may be impossible to measure reliably by conventional enzyme-linked immunosorbent assay; thus more sensitive methods, such as the HPLC/MS used in our study, are necessary.
Conclusion
To our best knowledge, this is the first study of markers of oxidative stress in patients with silicosis. In silicotics, the mean level of 8-isoprostane and leukotriene D4 in exhaled breath condensate was increased. This finding is in agreement with experimental studies and is biologically plausible given that silica particles persist in the lungs for decades. In rats, silicotic nodules continued to grow even after inhalational exposure to silica was discontinued 32) . Progressive fibrosis is also true in patients with chronic silicosis. It thus appears plausible that markers of inflammation and oxidative stress are increased and could point to the continuing process of fibrosis.
These results support the hypothesis that silica is the main cause of increased 8-isoprostane and leukotriene D in exhaled breath condensate. However, additional factors influencing the balance in antioxidant/oxidant status probably play contributing roles. Even if the clinical significance of increased 8-isoprostane and leukotriene D4 in the EBC is not yet sufficiently clear, silica appears to be the main factor, as these markers were positively associated with the silica exposure level and category of complicated silicosis.
This study supports the opinion that non-invasive EBC analysis is useful and contributes to elucidating processes in the respiratory system deriving from this incurable progressive disease.
